GO Term | Evidence Code | PMID |
---|---|---|
negative regulation of reactive oxygen species biosynthetic process | ||
epidermis development | ||
positive regulation of lipid biosynthetic process | ||
negative regulation of sequestering of triglyceride | ||
heart development |
GO Term | Evidence Code | PMID |
---|---|---|
RNA polymerase II-specific DNA-binding transcription factor binding | ||
DNA-binding transcription factor activity | ||
nuclear receptor activity | ||
DNA-binding transcription activator activity, RNA polymerase II-specific | ||
zinc ion binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:10652 | Alzheimer's disease | |
DOID:10763 | hypertension | |
DOID:10908 | hydrocephalus | |
DOID:12351 | alcoholic hepatitis | |
DOID:1485 | cystic fibrosis | |
DOID:3146 | lipid metabolism disorder | |
DOID:3393 | coronary artery disease | |
DOID:5419 | schizophrenia | |
DOID:5844 | myocardial infarction | |
DOID:684 | hepatocellular carcinoma |
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
105819376 | PROCO26826 | ||
109112747 | CYPCA138744 | ||
103743416 | NANGA07036 | ||
116442479 | CORMO19339 | ||
115605706 | STRHB22073 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024